Objective: We investigated serum lipid levels in asymptomatic HBsAg carriers and the general population using the Korean National Health and Nutrition Examination Survey (KNHANES). Methods: We analyzed the data of patients aged ≥30 years from the KNHANES 2007-2014 datasets. Subjects with diabetes mellitus, triglyceride levels >1000 mg/dL, a history of heavy alcohol consumption, or lipid-lowering medication were excluded. HBsAg carriers were divided into "unknown HBsAg carrier" and "known HBsAg carrier" according to previous self-recognition of HBsAg status using a questionnaire. Results: Compared with control subjects (n=24,880; male 33.9%; mean age 52±14 years), HBsAg carriers (n=1,061; male 40.6%; mean age 50±13 years) showed significantly higher AST and ALT levels, lower platelet counts and higher body mass index (BMI) (all p<0.001). HBsAg carriers revealed lower total cholesterol, LDL cholesterol and triglyceride levels (all p<0.001) compared with control subjects, irrespective of previous awareness of HBsAg positivity. Hypertriglyceridemia and low HDL cholesterolemia were less prevalent even in the "unknown HBsAg carrier" group compared with control subjects [age, sex and BMI-adjusted odds ratio, 0.566 (95% confidence interval, 0.468-0.684) and 0.822 (0.708-0.956), respectively]. Conclusion: In conclusion, HBsAg carriers exhibited low total cholesterol, LDL cholesterol, and triglyceride levels compared with control subjects. Hypertriglyceridemia and low HDL cholesterolemia were also less frequently detected in HBsAg carriers even after adjustments for age, sex, and BMI. 
INTRODUCTION
Liver diseases can alter serum lipid levels by altering lipoprotein synthesis, secretion and catabolism.
1,2 Subjects with chronic hepatitis have lower low-density lipoprotein (LDL), high-density lipoprotein (HDL) and total cholesterol levels and lower triglyceride level, when compared with healthy subjects. 2 These decreases in lipid levels become more prominent as the disease advances. 2 Hepatitis C virus (HCV) infection is well-known to directly affect lipid metabolism aside from liver function; HCV interferes with lipid metabolism via impaired lipoprotein secretion, increased lipogenesis, and impaired fatty acid degradation. 3 HCV infection is closely associated with insulin resistance, and each can aggravate the course of the other. 3 no association between insulin resistance and histologic severity among chronic HBV-infected subjects. 4, 5 However, controversy exists concerning the association between HBV infection and insulin resistance or lipid metabolism. 6, 7 A Korean group recently reported that chronic HBV infection was associated with increased insulin resistance and high cholesterol levels, when compared with that of healthy controls. 6 As chronic HBV infection is more popular in the Korean population, as compared with Caucasians, it may be important to investigate whether HBV infection affects insulin resistance or lipid metabolism in the Korean population.
The present study used Korean National Health and Nutrition Examination Survey (KNHANES) data, which is a nationwide survey that includes the HBV surface antigen 
MATERIALS AND METHODS

Subjects
The present analysis of patients aged ≥30 years was conducted using data from KNHANES 2007-2014, which is a nationwide survey conducted by the Ministry of Health )". 13 The FIB-4
index was developed as a marker of fibrosis in HCV-related hepatitis 13 and it is also useful for detecting significant fibrosis and cirrhosis in HBV-infected patients. 14 
Statistical analyses
All statistical analyses were performed using a complex sample design using SPSS version 20.0 (SPSS IBM Co., Armonk, NY, U.S. 28.6%, p=0.003); both fasting insulin and HOMA-IR were also significantly higher in HBsAg carriers compared with control subjects (both p<0.001). However, the prevalence of metabolic syndrome was significantly lower in HBsAg carriers compared with control subjects (21.7% vs. 25.6%, (Table 1) .
On comparing control subjects with "unknown HBsAg carriers" alone, the same patterns were maintained.
Compared with control subjects, "unknown HBsAg carriers" also had significantly higher AST and ALT levels (both p<0.001), higher fasting insulin and HOMA-IR levels (both p<0.001), higher prevalence of obesity (p=0.014), and significantly lower levels of total cholesterol, LDL cholesterol, and triglyceride (p<0.001, p=0.001 and p<0.001, respectively; Table 1 ).
As there was statistically significant differences in age, stratified analysis according to age was subsequently performed. Although statistical significance could not be gained in a few age-groups due to a limited number of subjects in each group, the same findings were found in these stratified analyses: HBsAg carriers exhibited lower total cholesterol, LDL cholesterol, and triglyceride levels when compared with control subjects in each age group (Fig. 1) levels compared with control subjects (p=0.019). On comparing control subjects with "unknown HBsAg carriers" alone, the same tendency was noted. "Unknown HBsAg carriers" exhibited lower total cholesterol, LDL cholesterol, and triglyceride levels compared with control subjects in each age group (Fig. 1) .
To exclude patients with cirrhosis, cholesterol levels were subsequently analyzed in participants with an FIB-4 index <1.45, as an FIB-4 index <1.45 has a negative predictive value of 90% for advanced fibrosis. 13 
Prevalence of metabolic syndrome and obesity according to HBsAg status
Prevalence of metabolic syndrome was decreased in HBsAg carriers irrespective of HBsAg awareness status, even after adjustment for age, sex, and BMI (Table 2 ).
Among components of metabolic syndrome, hypertriglyceridemia and low HDL cholesterolemia were less frequently found even in "unknown HBsAg carriers", when compared with control subjects, even after adjustment Frequency of alcohol drinking more than 60 g (40 g for women) of alcohol when compared with control subjects, even after adjustment for age, sex, and BMI (Table 2 ). In contrast, obesity was more prevalent in "unknown HBsAg carriers" when compared with control subjects (age and sex-adjusted OR, 1.207; 95% CI, 1.040-1.400). The prevalence of abdominal obesity, impaired fasting glucose or high blood pressure exhibited no difference between "unknown HBsAg carriers" and control subjects after adjustment for age and sex ( Table 2) .
As there was a statistically significant difference in age and sex among HBsAg status, age and sex-stratification analysis was performed. Although statistical significance could not be detected due to the limited number of subjects in each age-and sex-stratified group, the same tendency was found after stratified analyses for the association between HBsAg status and hypertriglyceridemia, low HDL cholesterolemia and obesity (Supplementary Fig. 1 ).
Energy intake and health-related activity in daily life according to HBsAg status
To investigate whether there was a difference in lifestyle associated with metabolic disease according to HBsAg status, energy intake and exercise were compared between control subjects and HBsAg carriers. HBsAg carriers showed a significantly higher daily total energy intake compared with control subjects (Table 3 ). The amount of daily protein intake, fat intake and carbohydrate intake was also increased in HBsAg carriers when compared with control subjects (Table 3) .
There was no difference in the prevalence of subjects performing aerobic exercise or resistance exercise among the groups and no difference was found in the frequency of alcohol intake (Table 3) . Current smoking status was more prevalence in HBsAg carriers, compared with that www.lipid.or.kr (Table 3 ).
The association between lipid levels and HBsAg titer
The association between lipid levels and HBsAg titer was investigated among HBsAg carriers. Among serum lipid levels, total cholesterol levels showed a significant negative correlation with HBsAg titer even after adjustment for age, sex, and BMI (p=0.009; Table 4 ).
HBsAg titer also exhibited a trend of negative association with LDL cholesterol (p=0.073) and triglyceride (p=0.072) levels.
DISCUSSION
Using nationwide health and nutrition examination datasets, the present study showed that HBV carriers have lower LDL cholesterol and triglyceride levels compared with control subjects, irrespective of the previous awareness status of HBsAg positivity. HBsAg carriers also showed a tendency for higher HDL cholesterol levels despite its relatively low statistical significance. Owing to lower prevalence of hypertriglyceridemia and low HDL-cholesterolemia, the prevalence of metabolic syndrome was significantly lower in HBsAg carriers, even in those who were previously unaware of their HBsAg positivity. A previous epidemiologic study in the Chinese population also showed that the likelihood of developing metabolic syndrome was 26% lower in HBsAg-positive subjects than control subjects. 16 This is an interesting finding considering that HBV carriers were more insulin resistant and more obese when compared with the control subjects in our study population. Low cholesterol and triglyceride levels in HBsAg carriers in the present study may be in the line with the findings observed in advanced liver disease. There are several limitations to this study. Firstly, since this is a cross-sectional study, a causal relationship could not be proven. We could not show the mechanism underlying not only the association between lipid prolife and HBsAg status but also the discrepancy between prevalence of dyslipidemia and insulin resistance according to HBsAg status. Secondly, the questionnaires were self-reported, and may have been subjected to recall bias.
However, the strength of our study is that data were analyzed from a nationwide survey using a large number of individuals. Notably, inclusion of a relatively large number of HBsAg carriers who were previously unaware of their HBsAg status (n=827) may reduce the bias from health pursuits associated with an awareness of HBsAg positivity.
In conclusion, HBsAg carriers exhibited low total cholesterol, LDL cholesterol, and triglyceride levels compared with control subjects. Hypertriglyceridemia, low HDL cholesterolemia and metabolic syndrome were also less frequently detected in HBsAg carriers, even after adjustments for age, sex, and BMI.
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